Tag: breast

When to Stop Cancer Screening: Clinicians’ Calculus Varies

Clinicians more often use a strict age cutoff for stopping colon cancer screening than they do for stopping breast and prostate cancer screening, new data...

No Benefit Seen With Everolimus in Early Breast Cancer

Adding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy alone, according to results of...

New Approach to Breast Screening Based on Breast Density at 40

A new approach to breast screening proposes that all women should have a baseline  evaluation of breast density by mammography at the age of 40....

Study Flags Cardiovascular Disease in Men With Breast Cancer

Cardiovascular disease and related risk factors can be common among male breast cancer patients, suggests a small study in this rare malignancy. Among 24 male...

First Mammography Guidelines for Older Breast Cancer Survivors

The first guidelines ever released for screening mammography for older survivors of breast cancer (>75 years) recommend that routine mammography be discontinued for women whose...

Tool Predicts Severe Toxicity From Chemo in Breast Cancer

A new tool for predicting the risk of severe chemotherapy toxicity in older adults with early-stage breast cancer outperforms existing models and should help older...

Entinostat Doesn’t Overcome Endocrine Resistance in Breast Cancer

The histone deacetylase (HDAC) inhibitor entinostat failed to overcome resistance to endocrine therapy in hormone receptor–positive, HER2-negative, advanced breast cancer in a phase 3 trial....

After 48 Years, NCI Aims to Track Breast Cancer Recurrences

  Patients with breast cancer want accurate information on the risk of their cancer recurring once they have completed treatment. “I would like to know...

Even for Wealthy, US Healthcare Can’t Match Care in Other Nations

(Reuters Health) – When it comes to health care, even privileged white Americans fare worse than the average citizens of 12 other developed countries, a...

Doctors Underreport Side Effects of Breast Irradiation

There is a substantial mismatch between patient and physician reports of toxicity during radiotherapy for breast cancer, according to an analysis of nearly 10,000 U.S....

Most Common Cancer Diagnosis Globally: Breast Surpasses Lung

Breast cancer now tops the list of the most commonly diagnosed cancers worldwide, surpassing lung cancer for the first time, according to the latest global...

Even More Women May Forgo Chemo for Breast Cancer

More women with early-stage breast cancer may safely forgo chemotherapy, suggests an interim analysis that had a median follow-up of 5 years of the large-scale...

Palbociclib Disappoints in HR+, HER2– Breast Cancer

The CDK4/6 inhibitor palbociclib provides no significant benefit in patients with hormone receptor–positive (HR+), HER2-negative primary breast cancer, according to first results from the PENELOPE-B...

Immediate Breast Reconstruction Feasible Following Neoadjuvant Chemo

NEW YORK (Reuters Health) – Long-term oncologic outcomes following neoadjuvant chemotherapy for breast cancer are similar with immediate breast reconstruction and conventional mastectomy alone, regardless...

New Assay Platform Enhances Detection of Circulating Breast Cancer Cells

NEW YORK (Reuters Health) – Detection of circulating tumor cells (CTCs) in a breast cancer model was improved by a novel assay platform that uses...

‘Glass Ceiling Shattered’ by Female Breast Surgeons. How?

In the United States, the field of surgery is dominated by men, but women have broken through in one subspecialty ― breast surgery. During the...

New Thermography Shows Efficacy for Breast Cancer Screening

Sensitivity and area under the curve (AUC) analyses of thermography that is combined with diagnostic software demonstrate “the efficacy of the tool for breast cancer...

pCR in HER2+ Breast Cancer Predicts Long-Term Survival

A pathologic complete response (pCR) to targeted therapy in HER2-positive breast cancer portends good long-term outcomes, according to final results of the phase 3 NeoALTTO/BIG...

Image-Guided Biopsy May Help Some Avoid Breast Cancer Surgery

NEW YORK (Reuters Health) – Following neoadjuvant chemotherapy, image-guided vacuum-assisted biopsy (VAB) can reliably identify a subgroup of patients with no residual disease in the...

Textured Implants Linked to Increased Breast Cancer Recurrence Risk

NEW YORK (Reuters Health) – Using textured implants for reconstruction after mastectomy is associated with greater risk of breast cancer recurrence compared to smooth implants,...

HRT Update Regarding Breast Cancer Risk Advised in EU

In concluding their review of hormone replacement therapy (HRT) and the associated risk of breast cancer, the EU Pharmacovigilance Risk Assessment Committee (PRAC) has recommended...

Cognitive Decline With Endocrine Tx for Breast Ca

Cognitive impairment seen in women with early breast cancer who undergo chemotherapy ― so-called chemobrain ― has now been reported in patients who are treated...